180 related articles for article (PubMed ID: 38036545)
1. NTHL1 is a recessive cancer susceptibility gene.
Nurmi AK; Pelttari LM; Kiiski JI; Khan S; Nurmikolu M; Suvanto M; Aho N; Tasmuth T; Kalso E; Schleutker J; Kallioniemi A; Heikkilä P; ; Aittomäki K; Blomqvist C; Nevanlinna H
Sci Rep; 2023 Nov; 13(1):21127. PubMed ID: 38036545
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the role of NTHL1 p.Q90* allele in inherited breast cancer predisposition.
Kumpula T; Tervasmäki A; Mantere T; Koivuluoma S; Huilaja L; Tasanen K; Winqvist R; de Voer RM; Pylkäs K
Mol Genet Genomic Med; 2020 Nov; 8(11):e1493. PubMed ID: 32949222
[TBL] [Abstract][Full Text] [Related]
3. Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.
Broderick P; Dobbins SE; Chubb D; Kinnersley B; Dunlop MG; Tomlinson I; Houlston RS
Gastroenterology; 2017 Jan; 152(1):75-77.e4. PubMed ID: 27713038
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing of Finnish hereditary breast cancer families.
Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108
[TBL] [Abstract][Full Text] [Related]
5. Further delineation of the NTHL1 associated syndrome: A report from the French Oncogenetic Consortium.
Boulouard F; Kasper E; Buisine MP; Lienard G; Vasseur S; Manase S; Bahuau M; Barouk Simonet E; Bubien V; Coulet F; Cusin V; Dhooge M; Golmard L; Goussot V; Hamzaoui N; Lacaze E; Lejeune S; Mauillon J; Beaumont MP; Pinson S; Tlemsani C; Toulas C; Rey JM; Uhrhammer N; Bougeard G; Frebourg T; Houdayer C; Baert-Desurmont S
Clin Genet; 2021 May; 99(5):662-672. PubMed ID: 33454955
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Characterization of Biallelic and Monoallelic
Salo-Mullen EE; Maio A; Mukherjee S; Bandlamudi C; Shia J; Kemel Y; Cadoo KA; Liu Y; Carlo M; Ranganathan M; Kane S; Srinivasan P; Chavan SS; Donoghue MTA; Bourque C; Sheehan M; Tejada PR; Patel Z; Arnold AG; Kennedy JA; Amoroso K; Breen K; Catchings A; Sacca R; Marcell V; Markowitz AJ; Latham A; Walsh M; Misyura M; Ceyhan-Birsoy O; Solit DB; Berger MF; Robson ME; Taylor BS; Offit K; Mandelker D; Stadler ZK
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250384
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
8. Six case reports of NTHL1-associated tumor syndrome further support it as a multi-tumor predisposition syndrome.
Weatherill CB; Burke SA; Haskins CG; Berry DK; Homer JP; Demeure MJ; Darabi S
Clin Genet; 2023 Feb; 103(2):231-235. PubMed ID: 36196035
[TBL] [Abstract][Full Text] [Related]
9. Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer.
Neidhardt G; Hauke J; Ramser J; Groß E; Gehrig A; Müller CR; Kahlert AK; Hackmann K; Honisch E; Niederacher D; Heilmann-Heimbach S; Franke A; Lieb W; Thiele H; Altmüller J; Nürnberg P; Klaschik K; Ernst C; Ditsch N; Jessen F; Ramirez A; Wappenschmidt B; Engel C; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
JAMA Oncol; 2017 Sep; 3(9):1245-1248. PubMed ID: 28033443
[TBL] [Abstract][Full Text] [Related]
10. NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?
Weren RD; Ligtenberg MJ; Geurts van Kessel A; De Voer RM; Hoogerbrugge N; Kuiper RP
J Pathol; 2018 Feb; 244(2):135-142. PubMed ID: 29105096
[TBL] [Abstract][Full Text] [Related]
11. Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Nurmi A; Muranen TA; Pelttari LM; Kiiski JI; Heikkinen T; Lehto S; Kallioniemi A; Schleutker J; Bützow R; Blomqvist C; Aittomäki K; Nevanlinna H
Int J Cancer; 2019 Nov; 145(10):2692-2700. PubMed ID: 30927251
[TBL] [Abstract][Full Text] [Related]
12. Intestinal and extraintestinal neoplasms in patients with NTHL1 tumor syndrome: a systematic review.
Beck SH; Jelsig AM; Yassin HM; Lindberg LJ; Wadt KAW; Karstensen JG
Fam Cancer; 2022 Oct; 21(4):453-462. PubMed ID: 35292903
[TBL] [Abstract][Full Text] [Related]
13. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer.
Weren RD; Ligtenberg MJ; Kets CM; de Voer RM; Verwiel ET; Spruijt L; van Zelst-Stams WA; Jongmans MC; Gilissen C; Hehir-Kwa JY; Hoischen A; Shendure J; Boyle EA; Kamping EJ; Nagtegaal ID; Tops BB; Nagengast FM; Geurts van Kessel A; van Krieken JH; Kuiper RP; Hoogerbrugge N
Nat Genet; 2015 Jun; 47(6):668-71. PubMed ID: 25938944
[TBL] [Abstract][Full Text] [Related]
14. Monoallelic NTHL1 Loss-of-Function Variants and Risk of Polyposis and Colorectal Cancer.
Elsayed FA; Grolleman JE; Ragunathan A; ; Buchanan DD; van Wezel T; de Voer RM
Gastroenterology; 2020 Dec; 159(6):2241-2243.e6. PubMed ID: 32860789
[No Abstract] [Full Text] [Related]
15. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
16. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Girard E; Eon-Marchais S; Olaso R; Renault AL; Damiola F; Dondon MG; Barjhoux L; Goidin D; Meyer V; Le Gal D; Beauvallet J; Mebirouk N; Lonjou C; Coignard J; Marcou M; Cavaciuti E; Baulard C; Bihoreau MT; Cohen-Haguenauer O; Leroux D; Penet C; Fert-Ferrer S; Colas C; Frebourg T; Eisinger F; Adenis C; Fajac A; Gladieff L; Tinat J; Floquet A; Chiesa J; Giraud S; Mortemousque I; Soubrier F; Audebert-Bellanger S; Limacher JM; Lasset C; Lejeune-Dumoulin S; Dreyfus H; Bignon YJ; Longy M; Pujol P; Venat-Bouvet L; Bonadona V; Berthet P; Luporsi E; Maugard CM; Noguès C; Delnatte C; Fricker JP; Gesta P; Faivre L; Lortholary A; Buecher B; Caron O; Gauthier-Villars M; Coupier I; Servant N; Boland A; Mazoyer S; Deleuze JF; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Int J Cancer; 2019 Apr; 144(8):1962-1974. PubMed ID: 30303537
[TBL] [Abstract][Full Text] [Related]
17. NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.
Belhadj S; Quintana I; Mur P; Munoz-Torres PM; Alonso MH; Navarro M; Terradas M; Piñol V; Brunet J; Moreno V; Lázaro C; Capellá G; Valle L
Sci Rep; 2019 Jun; 9(1):9020. PubMed ID: 31227763
[TBL] [Abstract][Full Text] [Related]
18. One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene.
Fostira F; Kostantopoulou I; Apostolou P; Papamentzelopoulou MS; Papadimitriou C; Faliakou E; Christodoulou C; Boukovinas I; Razis E; Tryfonopoulos D; Barbounis V; Vagena A; Vlachos IS; Kalfakakou D; Fountzilas G; Yannoukakos D
J Med Genet; 2020 Jan; 57(1):53-61. PubMed ID: 31300551
[TBL] [Abstract][Full Text] [Related]
19. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
[TBL] [Abstract][Full Text] [Related]
20. A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery.
Chandler MR; Bilgili EP; Merner ND
Hum Mutat; 2016 Sep; 37(9):835-46. PubMed ID: 27226120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
